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Method : This report is based on 9 human brain tissues, obtained from the Department of Pathology of the Lausanne University Hospital (CHUV): 3 Parkinson patients (Number A0200269, A0300080 and A0300084), 3 Alzheimer patients (A0800047, A0500097 and A0700131) and 3 control patients (A0900090, A0900100 and A0900079). All human material is acquired in accordance with the CHUV local ethical committee. Three different steps were necessary to complete this study : immunohistochemistry optimization, data collection and result analysis. Immunohistochemistry optimization : The first step of the study was to optimize the protocol used for staining of the 5 μm thick formalin fixed paraffin embedded brain sections with DCX. After several trials to find the correct dilution and the right antibody, the protocol used in this study was established : ‐ Dry the sections at 52°C for 30 min to melt the paraffin ‐ Hydration of brain sections : sequentially histosolve by dipping back and forth 10 times each in alcohol 100%, 94% and 70% ‐ Wash 1 time with tap water ‐ Wash 1 time quickly with PBS 1x ‐ Wash in PBS 1x for 2x 5 min ‐ Pre‐heat Tris‐EDTA pH 9.0 for 3 min in microwave ‐ Put the sections in Tris‐EDTA for 10 min in microwave for antigen retrieval ‐ Wash 1 time quickly with PBS 1x, then 2x 5 min in PBS 1x ‐ Put the sections in 3% H2O2 in H2O for 10 min for quenching ‐ Wash 1 time quickly with PBS 1x, then 2x 5 min in PBS 1x ‐ Blocking : 30 min in PBS‐Casein 0.5% and NGS 5% ‐ Primary Antibody (AB2253 guinea pig anti-DCX) overnight in PBS‐Casein 0.25% at 4°C at 1/200 μl 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‐ Wash 2x quickly then for 2x 10 min in PBS 1x ‐ Secondary Antibody (goat anti-guinea pig biotinylated (Vector, Burlingame, CA, 






















blood  vessels  are  good  fixed 
references  because  they  are 
unchanged  through  the  different 
sections  of  one  patient  used  for 
different  staining. By matching  those 
vessels on another staining, we would 












Methodological results: The first part of this study was optimization of the staining technique for an optimal cell counting by the software. At the beginning, we didn’t have satisfactory staining on the sections; indeed the sections were either inhomogeneously stained, or not stained at all. So we had to change this situation by modifying some parameters in the protocol. First of all, two primary antibodies were available: AB18723 rabbit anti-DCX and 
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